Phase 3 is the final and most extensive stage of clinical trials before regulatory approval. It involves testing a drug or treatment on large populations to confirm its efficacy, evaluate safety, and compare outcomes against existing standard therapies. Data from Phase 3 trials are critical for determining whether a new medical intervention can be approved for public use by agencies such as the FDA or EMA.